Benitec Biopharma (BNTC) Current Leases (2020 - 2025)
Benitec Biopharma (BNTC) posted Current Leases of $468000.0 for Q4 2025, up 13.04% sequentially from $414000.0 in Q3 2025.
Benitec Biopharma (BNTC) Current Leases (2020 - 2025) Analysis & Trends
Benitec Biopharma has reported Current Leases for 6 years, with the latest figure at $468000.0 in Q4 2025.
- Quarterly Current Leases changed N/A year-over-year to $468000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $468000.0 (changed N/A YoY) and the FY2025 annual result came in at $354000.0, up 24.65% from the prior year.
- Current Leases grew to $468000.0 in Q4 2025 per BNTC's latest filing, from $414000.0 in the prior quarter.
- Over five years, Current Leases peaked at $468000.0 in Q4 2025 and troughed at $194000.0 in Q3 2021.
- A 5-year average of $279578.9 and a median of $269000.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases declined 24.64% in 2024, then surged 96.21% in 2025.
- Over 5 years, Current Leases stood at $213000.0 in 2021, then gained by 23.47% to $263000.0 in 2022, then rose by 8.75% to $286000.0 in 2023, then decreased by 26.22% to $211000.0 in 2024, then surged by 121.8% to $468000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $468000.0, $414000.0, and $354000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 468,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 468,000.00 |
| Sep 30, 2025 | 414,000.00 |
| Jun 30, 2025 | 354,000.00 |
| Mar 31, 2025 | 346,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Jun 30, 2024 | 284,000.00 |
| Mar 31, 2024 | 292,000.00 |
| Dec 31, 2023 | 286,000.00 |
| Sep 30, 2023 | 280,000.00 |
| Jun 30, 2023 | 275,000.00 |
| Mar 31, 2023 | 269,000.00 |
| Dec 31, 2022 | 263,000.00 |
| Sep 30, 2022 | 258,000.00 |
| Jun 30, 2022 | 252,000.00 |
| Mar 31, 2022 | 232,000.00 |
| Dec 31, 2021 | 213,000.00 |
| Sep 30, 2021 | 194,000.00 |
| Jun 30, 2021 | 213,000.00 |
| Mar 31, 2021 | 208,000.00 |
| Dec 31, 2020 | 203,000.00 |